2026 NPPES data Neurology Physician NPI 1144227638 M.D.
Verify on CMS →

INDRAVADAN GATIWALA, M.D.

Neurology Physician in LUMBERTON, North Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 476 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.3908/100
▲ 6 pts above national avg 83.1 · [object Object]
Industry payments
$1.5K
78 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: INDRAVADAN GATIWALA, M.D. is a Neurology Physician ([object Object]) practicing in LUMBERTON, North Carolina with a Medicare Part D prescribing footprint of 4K claims across 476 beneficiaries — 18% brand-name prescribing . Their CMS MIPS Final Score of 89.3908/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.5K across 78 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: INDRAVADAN GATIWALA, M.D. reported a CMS MIPS final score of 89.3908 out of 100, above the 83.1 national average, and filed 4,403 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

INDRAVADAN GATIWALA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

INDRAVADAN GATIWALA, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/30/2005

NPI 1144227638

Primary specialty

Neurology Physician

Mid-sized

19,866 US NPIs in this specialty

Medicare Part D claims

4,403 236% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

MIPS final score

89.3908/100 6.290800000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in North Carolina

How Neurology Physician compares to other specialties among North Carolina providers

North Carolina providers

Neurology Physician share within North Carolina

1. Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neurology Physician share within North Carolina

Medicare quality performance — MIPS

INDRAVADAN GATIWALA, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average

High performer (top quartile)
MIPS Final Score
89.3908/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neurology Physician) — 89.3908/100 vs national avg 83.1

0%100%National avg83%89.4%
MIPS final score (Neurology Physician) — 89.3908/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

INDRAVADAN GATIWALA, M.D. is a Neurology Physician provider practicing in LUMBERTON, North Carolina, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1144227638. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

INDRAVADAN GATIWALA, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 785 OAKRIDGE BLVD, LUMBERTON, NC, 28358, with a listed phone of (910) 739-2343. NPI 1144227638 was issued on 06/30/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GATIWALA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,403 prescription claims written by this provider, covering 476 Medicare beneficiaries and totaling roughly $3.9 million in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.3908/100 for the 2023 performance year (Quality 66.1042), compared with the national average of 83.1.

Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

785 OAKRIDGE BLVD
LUMBERTON, NC 28358

Provider Details

NPI 1144227638
Specialty Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 06/30/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.3908
Final Score
Avg: 83.1
66.1042
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for INDRAVADAN GATIWALA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

JAZZ PHARMACEUTICALS INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

INDRAVADAN GATIWALA, M.D. — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 4,403 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,403
Total Claims
$3.9M
Total Drug Cost
476
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,712
Total Day Supply
164,321
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$3.7M
Generic Drug Cost
$181K

Patient Demographics

Average Patient Age
70.8 years
Avg HCC Risk Score
1.86
Gender Split
59% female / 41% male
Age Distribution
<65: 102, 65-74: 197, 75-84: 131, 85+: 46

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Memantine Hcl
536
Donepezil Hcl
377
Gabapentin
320
Ropinirole Hcl
235
Memantine Hcl Er
Memantine Hcl
198
Levetiracetam
132
Galantamine Hbr
119
Octagam
Immun Globg(Igg)/Malt/Iga Ov50
93
Divalproex Sodium
91
Lacosamide
90

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How INDRAVADAN GATIWALA, M.D. fits within the Neurology Physician landscape nationally.

19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

INDRAVADAN GATIWALA, M.D.'s 4,403 claims are above the specialty average of 1,309.

Nearby Neurology Physician Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as GATIWALA.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is INDRAVADAN GATIWALA, M.D.'s specialty?
INDRAVADAN GATIWALA, M.D. specializes in Neurology Physician and practices in LUMBERTON, North Carolina. Credentials: M.D..
How much does INDRAVADAN GATIWALA, M.D. prescribe under Medicare Part D?
In 2023, INDRAVADAN GATIWALA, M.D. wrote 4,403 Medicare Part D claims totaling $3.9M in drug costs for 476 beneficiaries.
What is INDRAVADAN GATIWALA, M.D.'s Medicare quality score?
INDRAVADAN GATIWALA, M.D. has a CMS MIPS Final Score of 89.3908/100 (Quality: 66.1042). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is INDRAVADAN GATIWALA, M.D. located?
INDRAVADAN GATIWALA, M.D. is located at 785 OAKRIDGE BLVD, LUMBERTON, NC, 28358. Phone: (910) 739-2343.
What is INDRAVADAN GATIWALA, M.D.'s NPI number?
INDRAVADAN GATIWALA, M.D.'s National Provider Identifier (NPI) is 1144227638, issued on 06/30/2005.
Does INDRAVADAN GATIWALA, M.D. prescribe more brand-name or generic drugs?
INDRAVADAN GATIWALA, M.D.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $3.7M in brand drug costs.
How many Neurology Physician providers are there in the US?
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does INDRAVADAN GATIWALA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, INDRAVADAN GATIWALA, M.D.'s most frequently prescribed drugs include Memantine Hcl, Donepezil Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does INDRAVADAN GATIWALA, M.D. accept Medicare?
INDRAVADAN GATIWALA, M.D. appears in CMS Medicare data with 4,403 Part D claims and 476 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify INDRAVADAN GATIWALA, M.D.'s credentials?
INDRAVADAN GATIWALA, M.D.'s NPI is 1144227638 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology